Citation Information :
Dharshini P. Endometrial Histology in Epithelial Ovarian Tumors: A Critical Analysis. J South Asian Feder Obs Gynae 2024; 16 (2):65-67.
Objective: The aim of the present study is to determine the prevalence of abnormal endometrial histology, premalignancy, and malignancy in women diagnosed with epithelial ovarian tumors and tumor-like conditions (PCOS, endometriosis, stromal hyperplasia, and stromal hyperthecosis).
Materials and methods: Endometrial and ovarian specimens of 71 patients with epithelial ovarian tumors were retrospectively selected, and the histopathology was analyzed. Moreover, 79% had serous tumors, 15.4% had mucinous tumors, and 5.6% other tumors (fibrothecoma, cystadenofibroma). Ovarian histopathology was compared with the concurrent endometrial pathology.
Results: Among the samples analyzed, 41% had abnormal endometrial histology, of which 29% is polypoidal endometrium and 12% is disordered proliferation, both of which represent hyperestrogenic state.
Conclusion: Abnormal endometrial histology due to stromal steroidogenesis and its biological action on endometrium is well-known; hence, endometrial evaluation is mandatory for planning treatment and understanding the disease process of epithelial ovarian tumors.
Blanco LZ Jr, Kuhn E, Morrison JC, et al. Steroid hormone synthesis by the ovarian stroma surrounding epithelial ovarian tumors: A potential mechanism in ovarian tumorigenesis. Mod Pathol 2017;30(4):563–576. DOI: 10.1038/modpathol.2016.219.
Hattori Y, Yamada S, Yamamoto M. Ovarian mucinous adenocarcinoma with functioning stroma in postmenopausal women: Aromatase and SF-1 expressions. J Ovarian Res 2015;8:73. DOI: 10.1186/s13048-015- 0202-y.
Matsumura S, Ohta T, Takahashi T, et al. Non-sex cord-stromal ovarian tumors frequently produce and secrete estrogen in postmenopausal women: impact on bone metabolism and abnormal endometrial histology. J Clin Endocrinol Metab 2013;98(7):2775–2782. DOI: 10.1210/jc.2013-1267.
Tanaka YO, Tsunoda H, Kitagawa Y, et al. Functioning ovarian tumors: direct and indirect findings at MR imaging. Radiographics 2004;24(Suppl. 1):S147–S166. DOI: 10.1148/rg.24si045501.
MacDonald PC, Grodin JM, Edman CD, et al. Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia. Obstet Gynecol 1976;47(6):644–650. PMID: 934553.
Singh N, Tripathi R, Mala YM, et al. Large functional benign endometroid cystadenofibroma of the ovary leading to endometrial cystic glandular hyperplasia and postmenopausal bleeding. BMJ Case Rep 2013;2013:bcr2013010323. DOI: 10.1136/bcr-2013-010323.
Rome RM, Fortune DW, Quinn MA, et al. Functioning ovarian tumors in postmenopausal women. Obstet Gynecol 1981;57(6):705. PMID: 7231823.
Mingels MJ, Masadah R, Geels YP, et al. High prevalence of atypical hyperplasia in the endometrium of patients with epithelial ovarian cancer. Am J Clin Pathol 2014;142(2):213–221. DOI: 10.1309/AJCPTGJOPXUW6RVO.
Yamagata S, Yamamoto K, Yamamoto K, et al. Estrogen production in epithelial tumors of the ovary–clinical and endocrinological study in postmenopausal women. Nihon Sanka Fujinka Gakkai Zasshi 1989;41(11):1761–1768. PMID: 2687406.
Hiramatsu K, Yoshino K, Serada S, et al. Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas. Br J Cancer 2016;114(5):554–561. DOI: 10.1038/bjc.2016.27.
Merritt MA, Cramer DW. Molecular pathogenesis of endometrial and ovarian cancer. Cancer Biomark 2010;9(1–6):287–305. DOI: 10.3233/CBM-2011-0167.
Li X, Feng Y, Lin JF, et al. Endometrial progesterone resistance and PCOS. J Biomed Sci 2014;21(1):2. DOI: 10.1186/1423-0127-21-2.
McCormick BA, Wilburn RD, Thomas MA, et al. Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome. Fertil Steril 2011;95(8):2625–2627. DOI: 10.1016/j.fertnstert.2011.04.022.
